精准医学与价值医疗时代的针刺活检充分性
本文综述针刺活检技术、器械与实践,指出当前活检充分性相对诊断需求仍有限,不足可导致诊断延迟、重复操作或治疗延迟并增加医疗成本;结论提出通过统一充分性标准、优化技术操作流程与专业教育质控、以及将活检费用与下游诊断捆绑来改进。
要点
- 针刺活检充分性不足可致诊断延迟、重复操作或治疗延迟并增加医疗系统成本。
- 改进方向包括推广统一的针刺活检充分性标准。
- 需优化穿刺技术、器械、临床实践、专业教育与质量保证,并捆绑活检与下游诊断费用。
核心结论
- 针刺活检充分性可通过认识其重要性、推广统一充分性标准、优化技术操作与教育质控、以及捆绑活检与下游诊断费用来改善。
研究设计与样本
- 通过PubMed检索细针穿刺和粗针活检器械及类似技术,按通用、组织部位、充分性和卫生经济学角度进行综述。
主要发现
- 针刺活检提供诊断和预后分析所需样本的能力相对当前诊断需求仍相当有限。
- 活检不充分常导致诊断延迟、操作重复或肿瘤生物学信息不足而延误治疗。
- 对卫生系统而言,活检不充分造成显著增量成本并低效使用稀缺专科诊断资源。
临床怎么用
- 应重视针刺活检作为诊断工具的重要性并推广统一的充分性标准。
- 优化穿刺操作技术、器械、临床实践、专业教育和质量保证以提升活检充分性。
- 将活检操作费用与下游诊断方式捆绑,以更好问责和激励改进诊断流程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: Needle biopsy of diseased tissue is an essential diagnostic tool that is becoming even more important as precision medicine develops. However, the capability of this modality to efficiently provide samples adequate for diagnostic and prognostic analysis remains quite limited relative to current diagnostic needs. For physicians and patients, inadequate biopsy frequently leads to diagnostic delay, procedure duplication, or insufficient information about tumor biology leading to delay in treatment; for health systems, this results in substantial incremental costs and inefficient use of scarce specialized diagnostic resources. OBJECTIVE.—: To review current needle biopsy technology, devices, and practice with a perspective to identify current limitations and opportunities for improvement in the context of advancing precision medicine. DATA SOURCES.—: PubMed searches of fine-needle aspiration and core needle biopsy devices and similar technologies were made generally, by tissue site, and by adequacy as well as by health economics of these technologies. CONCLUSIONS.—: Needle biopsy adequacy can be improved by recognizing the importance of this diagnostic tool by promoting common criteria for needle biopsy adequacy; by optimizing needle biopsy procedural technique, technologies, clinical practice, professional education, and quality assurance; and by bundling biopsy procedure costs with downstream diagnostic modalities to provide better accountability and incentives to improve the diagnostic process.
引用
- Pritzker KPH, Nieminen HJ. Needle Biopsy Adequacy in the Era of Precision Medicine and Value-Based Health Care. Arch Pathol Lab Med. 2019. PMID: 31100015. doi:10.5858/arpa.2018-0463-RA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。